View in EDS PDF Full Text

CD40L-Tri, a novel formulation of recombinant human CD40L that effectively activates B cells.

Saved in:
Bibliographic Details
Title: CD40L-Tri, a novel formulation of recombinant human CD40L that effectively activates B cells.
Authors: Naito M; Cancer Vaccine Center, Dana-Farber Cancer Institute, Boston, MA, USA., Hainz U, Burkhardt UE, Fu B, Ahove D, Stevenson KE, Rajasagi M, Zhu B, Alonso A, Witten E, Matsuoka K, Neuberg D, Duke-Cohan JS, Wu CJ, Freeman GJ
Source: Cancer immunology, immunotherapy : CII [Cancer Immunol Immunother] 2013 Feb; Vol. 62 (2), pp. 347-57. Date of Electronic Publication: 2012 Aug 25.
Publication Type: Journal Article; Research Support, N.I.H., Extramural; Research Support, Non-U.S. Gov't
Journal Info: Publisher: Springer Verlag Country of Publication: Germany NLM ID: 8605732 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 1432-0851 (Electronic) Linking ISSN: 03407004 NLM ISO Abbreviation: Cancer Immunol Immunother Subsets: MEDLINE
Database: MEDLINE Ultimate
FullText Links:
  – Type: pdflink
Text:
  Availability: 0
Header DbId: mdl
DbLabel: MEDLINE Ultimate
An: 22926059
AccessLevel: 2
PubType: Academic Journal
PubTypeId: academicJournal
PreciseRelevancyScore: 0
IllustrationInfo
Items – Name: Title
  Label: Title
  Group: Ti
  Data: CD40L-Tri, a novel formulation of recombinant human CD40L that effectively activates B cells.
– Name: Author
  Label: Authors
  Group: Au
  Data: <searchLink fieldCode="AU" term="%22Naito+M%22">Naito M</searchLink>; Cancer Vaccine Center, Dana-Farber Cancer Institute, Boston, MA, USA.<br /><searchLink fieldCode="AU" term="%22Hainz+U%22">Hainz U</searchLink><br /><searchLink fieldCode="AU" term="%22Burkhardt+UE%22">Burkhardt UE</searchLink><br /><searchLink fieldCode="AU" term="%22Fu+B%22">Fu B</searchLink><br /><searchLink fieldCode="AU" term="%22Ahove+D%22">Ahove D</searchLink><br /><searchLink fieldCode="AU" term="%22Stevenson+KE%22">Stevenson KE</searchLink><br /><searchLink fieldCode="AU" term="%22Rajasagi+M%22">Rajasagi M</searchLink><br /><searchLink fieldCode="AU" term="%22Zhu+B%22">Zhu B</searchLink><br /><searchLink fieldCode="AU" term="%22Alonso+A%22">Alonso A</searchLink><br /><searchLink fieldCode="AU" term="%22Witten+E%22">Witten E</searchLink><br /><searchLink fieldCode="AU" term="%22Matsuoka+K%22">Matsuoka K</searchLink><br /><searchLink fieldCode="AU" term="%22Neuberg+D%22">Neuberg D</searchLink><br /><searchLink fieldCode="AU" term="%22Duke-Cohan+JS%22">Duke-Cohan JS</searchLink><br /><searchLink fieldCode="AU" term="%22Wu+CJ%22">Wu CJ</searchLink><br /><searchLink fieldCode="AU" term="%22Freeman+GJ%22">Freeman GJ</searchLink>
– Name: TitleSource
  Label: Source
  Group: Src
  Data: <searchLink fieldCode="JN" term="%228605732%22">Cancer immunology, immunotherapy : CII</searchLink> [Cancer Immunol Immunother] 2013 Feb; Vol. 62 (2), pp. 347-57. <i>Date of Electronic Publication: </i>2012 Aug 25.
– Name: TypePub
  Label: Publication Type
  Group: TypPub
  Data: Journal Article; Research Support, N.I.H., Extramural; Research Support, Non-U.S. Gov't
– Name: TitleSource
  Label: Journal Info
  Group: Src
  Data: <i>Publisher: </i><searchLink fieldCode="PB" term="%22Springer+Verlag%22">Springer Verlag </searchLink><i>Country of Publication: </i>Germany <i>NLM ID: </i>8605732 <i>Publication Model: </i>Print-Electronic <i>Cited Medium: </i>Internet <i>ISSN: </i>1432-0851 (Electronic) <i>Linking ISSN: </i><searchLink fieldCode="IS" term="%2203407004%22">03407004 </searchLink><i>NLM ISO Abbreviation: </i>Cancer Immunol Immunother <i>Subsets: </i>MEDLINE
PLink https://search.ebscohost.com/login.aspx?direct=true&site=eds-live&db=mdl&AN=22926059
RecordInfo BibRecord:
  BibEntity:
    Identifiers:
      – Type: doi
        Value: 10.1007/s00262-012-1331-4
    Languages:
      – Code: eng
        Text: English
    PhysicalDescription:
      Pagination:
        StartPage: 347
    Titles:
      – TitleFull: CD40L-Tri, a novel formulation of recombinant human CD40L that effectively activates B cells.
        Type: main
  BibRelationships:
    HasContributorRelationships:
      – PersonEntity:
          Name:
            NameFull: Naito M
      – PersonEntity:
          Name:
            NameFull: Hainz U
      – PersonEntity:
          Name:
            NameFull: Burkhardt UE
      – PersonEntity:
          Name:
            NameFull: Fu B
      – PersonEntity:
          Name:
            NameFull: Ahove D
      – PersonEntity:
          Name:
            NameFull: Stevenson KE
      – PersonEntity:
          Name:
            NameFull: Rajasagi M
      – PersonEntity:
          Name:
            NameFull: Zhu B
      – PersonEntity:
          Name:
            NameFull: Alonso A
      – PersonEntity:
          Name:
            NameFull: Witten E
      – PersonEntity:
          Name:
            NameFull: Matsuoka K
      – PersonEntity:
          Name:
            NameFull: Neuberg D
      – PersonEntity:
          Name:
            NameFull: Duke-Cohan JS
      – PersonEntity:
          Name:
            NameFull: Wu CJ
      – PersonEntity:
          Name:
            NameFull: Freeman GJ
    IsPartOfRelationships:
      – BibEntity:
          Dates:
            – D: 01
              M: 02
              Text: 2013 Feb
              Type: published
              Y: 2013
          Identifiers:
            – Type: issn-electronic
              Value: 1432-0851
          Numbering:
            – Type: volume
              Value: 62
            – Type: issue
              Value: 2
          Titles:
            – TitleFull: Cancer immunology, immunotherapy : CII
              Type: main
ResultId 1